跳至主要内容
临床试验/ACTRN12616000116426
ACTRN12616000116426已完成4 期

A Randomized Controlled Trial (RCT) comparing reversal effect of rocuronium with neostigmine or sugammadex towards cough response on emergence in patients undergoing general anesthesia

Dr Loh Pui San0 个研究点目标入组 120 人开始时间: 2016年2月2日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Patients scheduled for elective or emergency operation under general relaxant anaesthesia
  • 2. ASA I - III according to American Society of Anaesthesiologist guidelines.
  • 3. Age 18 - 70 years old.
  • 4. Aim for extubation at the end of surgery
  • 5. Procedure duration of 1 hour to 6 hours

排除标准

  • 1. Patient refusal (or legal guardian)
  • 2. Planned to remain intubated and ventilated
  • 3. Patient on tracheostomy
  • 4. Any contraindication to rocuronium, neostigmine or sugammadex such as allergy, severe renal or liver impairment, coagulopathy and on OCP.
  • 5. Evidence of raised ICP or IOP
  • 6. Residual neuromuscular weakness affecting cough and gag

研究者

发起方
Dr Loh Pui San

相似试验